Impact of care by gynecologic oncologists on primary ovarian cancer survival: a population-based study
Bouchard-Fortier G, Gien LT, Sutradhar R, Chan WC, Krzyzanowska MK, Liu S, Ferguson SE. Gynecol Oncol. 2022; 164(3):522-8. Epub 2022 Jan 19.
Publications
Remote, proactive, telephone based management of toxicity in outpatients during adjuvant or neoadjuvant chemotherapy for early stage breast cancer: pragmatic, cluster randomised trial
Krzyzanowska MK, Julian JA, Gu C, Powis M, Li Q, Enright K, Howell D, Earle CC, Gandhi S, Rask S, Brezden-Masley C, Dent S, Hajra L, Freeman O, Spadafora S, Hamm C, Califaretti N, Trudeau M, Levine MN, Amir E, Bordeleau L, Chiarotto JA, Elser C, Husain J, Laferriere N, Rahim Y, Robinson AG, Vandenberg T, Grunfeld E. BMJ. 2021; 375:e066588. Epub 2021 Dec 8.
Primary care continuity and wait times to receiving breast cancer chemotherapy: a population-based retrospective cohort study using CanIMPACT data
Walsh RL, Lofters A, Moineddin R, Krzyzanowska M, Grunfeld E. Curr Oncol. 2021; 28(6):4786–804. Epub 2021 Nov 17.
Utilization rates of pancreatectomy, radical prostatectomy, and nephrectomy in New York, Ontario, and New South Wales, 2011 to 2018
Pang HYM, Chalmers K, Landon B, Elshaug AG, Matelski J, Ling V, Krzyzanowska MK, Kulkarni G, Erickson BA, Cram P. JAMA Netw Open. 2021; 4(4):e215477. Epub 2021 Apr 19.
The effect of comorbidity on primary care use during breast cancer chemotherapy: a population-based retrospective cohort study using CanIMPACT data
Walsh RL, Lofters AK, Moineddin R, Krzyzanowska MK, Grunfeld E. CMAJ Open. 2021; 9(2):E331-41. Epub 2021 Apr 1.
Outcomes after emergency department use in patients with cancer receiving chemotherapy in Ontario, Canada: a population-based cohort study
Grewal K, Krzyzanowska MK, McLeod S, Borgundvaag B, Atzema CL. CMAJ Open. 2020; 8(3):E496-505. Epub 2020 Aug 12.
Cross-Canada differences in early-stage breast cancer treatment and acute-care use
Powis M, Groome P, Biswanger N, Kendell C, Decker KM, Grunfeld E, McBride ML, Urquhart R, Winget M, Porter GA, Krzyzanowska MK; Canadian Team to Improve Community-Based Cancer Care Along the Continuum. Curr Oncol. 2019; 26(5):e624-39. Epub 2019 Oct 31.
Development and validation of a score to predict acute care use after initiation of systemic therapy for cancer
Grant RC, Moineddin R, Yao Z, Powis M, Kukreti V, Krzyzanowska MK. JAMA Netw Open. 2019; 2(10):e1912823. Epub 2019 Oct 9.
Estimating the optimal perioperative chemotherapy utilization rate for muscle-invasive bladder cancer
Karim S, Mackillop WJ, Brennan K, Peng Y, Siemens DR, Krzyzanowska MK, Booth CM. Cancer Med. 2019; 8(14):6258-71. Epub 2019 Aug 31.
Estimating the optimal rate of adjuvant chemotherapy utilization for stage III colon cancer
Karim S, Booth CM, Brennan K, Peng Y, Siemens DR, Krzyzanowska MK, Mackillop WJ. Cancer Med. 2019; 8(12):5590-9. Epub 2019 Aug 12.